Security key
34385P108
STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB)
CUSIP: 34385P108
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 46,157,930
- Total 13F value
- $89,085,103
- Share change
- +60,048
- Put/Call ratio
- 446%
- SEC-reported price per share
- $1.93
- Number of holders
- 65
- Value change
- +$111,792
- Number of buys
- 24
- Number of sells
- 39
- Shares outstanding
- 391,007,800
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
65
Top holders
10
LAB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2023
Previous quarter: Q1 2023
STANDARD BIOTOOLS INC. SEC filings
STANDARD BIOTOOLS INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 34385P108
Recent filing periods:
Ownership snapshot
Top reported holders of LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Caligan Partners LP
Disclosed value leader
Caligan Partners LP
Comparable rows
15/15
Latest evidence
29 Jun 2023
3/4/5
13F
Lead comparable stake: 2.2%
Showing 1-6 of 15 holder rows.
Quick read
Caligan Partners LP leads the comparable SEC ownership view at 2.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Caligan Partners LP's linked filing trail.
Comparable ownership
Top 5
Caligan Partners LP
2.2%
Indaba Capital Management, L.P.
1.9%
Neuberger Berman Group LLC
1.2%
PRIMECAP MANAGEMENT CO/CA/
1.2%
VANGUARD GROUP INC
1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Caligan Partners LP |
3/4/5
13F
10%+ Owner · Company
|
2.2%
from 13F
|
$34,539,714
16,265,374 shares
mixed-class rows
|
— | 29 Jun 2023 |
| Indaba Capital Management, L.P. |
13F
Company
|
1.9%
|
$14,520,147
7,446,229 shares
|
— | 31 Mar 2023 |
| Neuberger Berman Group LLC |
13F
Company
|
1.2%
|
$8,810,749
4,508,776 shares
|
— | 31 Mar 2023 |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
Company
|
1.2%
|
$8,770,267
4,497,573 shares
|
— | 31 Mar 2023 |
| VANGUARD GROUP INC |
13F
Company
|
1%
|
$7,714,137
3,955,968 shares
|
— | 31 Mar 2023 |
| MORGAN STANLEY |
13F
Company
|
0.82%
|
$6,232,729
3,196,271 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
65
Shares
46,157,930
Rows available
65
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
68
Q2 2023 holders
65
Holder diff
-3
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend